# HMPL-A580 in Participants With Advanced or Metastatic Solid Tumor

> **NCT07396584** · PHASE1,PHASE2 · RECRUITING · sponsor: **Hutchmed** · enrollment: 186 (estimated)

## Conditions studied

- Solid Tumors, Adult

## Interventions

- **DRUG:** HMPL-A580
- **DRUG:** HMPL-A580

## Key facts

- **NCT ID:** NCT07396584
- **Lead sponsor:** Hutchmed
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-03-04
- **Primary completion:** 2028-12-31
- **Final completion:** 2029-01-30
- **Target enrollment:** 186 (ESTIMATED)
- **Last updated:** 2026-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07396584

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07396584, "HMPL-A580 in Participants With Advanced or Metastatic Solid Tumor". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07396584. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*